SEAN MARKER: Open Payments
NPI 1104852011 · DORCHESTER CENTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 12 payments from 5 companies in 2025. Trend: 2023 $36 · 2024 $135 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $103 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: INGREZZA, Jornay PM, CAPLYTA, REXULTI, AUSTEDO XR.
Industry payments across MA — which companies pay providers there.
